All Products

Insulia
Insulia

Insulia®, available via mobile app or web portal, is a prescription-only medical device that recommends basal insulin doses for adults with Type 2 diabetes based on the treatment plan created by the healthcare provider.

Oleena
Oleena

Oleena® is a prescription mobile app for cancer patients, designed to help them in the management of their symptoms and enable remote monitoring by care teams.

Freespira
Freespira

Freespira is indicated (FDA-cleared) as an adjunctive treatment of symptoms associated with panic disorder, panic attacks and/or PTSD in patients 18 and older.

Luminopia One
Luminopia One

Luminopia™ One is an FDA Cleared prescription digital therapeutic indicated for improvement in visual acuity in amblyopia patients aged 4-7.

RelieVRx
RelieVRx

RelieVRx (formerly EaseVRx) is an FDA Cleared at-home immersive virtual reality (VR) pain treatment indicated as adjunctive treatment for chronic lower back pain (CLBP).

Mahana IBS
Mahana IBS

Mahana IBS is an FDA-cleared, clinically validated digital treatment for IBS. Apple App Store Rating: 4.7 (314 Reviews)

Nightware
Nightware

NightWare is an FDA cleared digital therapeutic to interrupt nightmares and improve sleep quality. Apple App Store Rating: 4.1 (11 Reviews)

Nerivio
Nerivio

Nerivio is a smartphone-controlled wearable, noninvasive device to relieve symptoms of a migraine that’s already started. The treatment is personalized through the Nerivio app, which also includes a migraine diary to track treatment sessions a [...]

EndeavorRx
EndeavorRx

EndeavorRx is a first-of-its-kind ADHD treatment for kids 8-12, delivered through an immersive video game experience on iPhone®, iPad® and Android™ devices.

reSET-O
reSET-O

reSET-O, the first PDT to receive Breakthrough Designation and authorized by FDA in December 2018, is an 84-day Prescription Digital Therapeutic (PDT) for Opioid Use Disorder (OUD).

reSET
reSET

reSET, the first Prescription Digital Therapeutic (PDT) to receive authorization from FDA to improve disease outcomes, is a 90-day PDT for Substance Use Disorder (SUD).

Product: Somryst
Product: Somryst

Somryst® is a prescription-only digital therapeutic intended to provide a neurobehavioral intervention (CBT-I) to patients 22 years of age and older with chronic insomnia. Apple App Store Rating: 4.1 (11 Reviews)